PreludeDx (@preludedx) 's Twitter Profile
PreludeDx

@preludedx

Developers of DCISionRT, the first biological risk signature designed specifically for ductal carcinoma in situ (DCIS).

Your Biology, Your Decision®

ID: 935917226443530240

linkhttp://www.preludedx.com calendar_today29-11-2017 17:03:50

634 Tweet

250 Followers

339 Following

PreludeDx (@preludedx) 's Twitter Profile Photo

Did you miss our webinar on the Limitations of Clinicopathology & Why DCISionRT Is Changing Practice in DCIS Radiation Decisions? Not to worry! Join Dr. Troy Bremer and Dr. Pat Whitworth for a recap on Tuesday, 8/19 at 3pm PST. đź”—: bit.ly/46XTdQK #DCIS #DCISionRT

Did you miss our webinar on the Limitations of Clinicopathology & Why DCISionRT Is Changing Practice in DCIS Radiation Decisions? Not to worry!

Join Dr. Troy Bremer and Dr. Pat Whitworth for a recap on Tuesday, 8/19 at 3pm PST.

đź”—: bit.ly/46XTdQK

#DCIS #DCISionRT
PreludeDx (@preludedx) 's Twitter Profile Photo

Looking to see if DCISionRT is in your area? Our website shows where physicians are who order our test. Enter your zip code, check out the map, then click on the link to contact our team—we will send you the information! bit.ly/4jYoDKh

Looking to see if DCISionRT is in your area? Our website shows where physicians are who order our test. Enter your zip code, check out the map, then click on the link to contact our team—we will send you the information!  bit.ly/4jYoDKh
PreludeDx (@preludedx) 's Twitter Profile Photo

“Biology matters.” Dr. Rakesh Patel shared this key takeaway in our recent webinar on Limitations of Clinicopathology & Why DCISionRT Is Changing Practice in DCIS Radiation Decisions. Watch Here: bit.ly/41sDx4m #DCIS #DCISionRT #PrecisionMedicine #SharedDecisionMaking

“Biology matters.”

Dr. Rakesh Patel shared this key takeaway in our recent webinar on Limitations of Clinicopathology & Why DCISionRT Is Changing Practice in DCIS Radiation Decisions.

Watch Here: bit.ly/41sDx4m

#DCIS #DCISionRT #PrecisionMedicine #SharedDecisionMaking
PreludeDx (@preludedx) 's Twitter Profile Photo

The PreludeDX team is excited to be headed to San Francisco for ASTRO 2025! Hear the latest from our Red Journal Clin-Path study, DCISionRT research, and what’s next with AidaBreast. So many ways to connect—we can’t wait to see you! #ASTRO25 #ASTRO #DCIS

The PreludeDX team is excited to be headed to San Francisco for ASTRO 2025! Hear the latest from our Red Journal Clin-Path study, DCISionRT research, and what’s next with AidaBreast. So many ways to connect—we can’t wait to see you! #ASTRO25 #ASTRO #DCIS
PreludeDx (@preludedx) 's Twitter Profile Photo

For the first time, radiation decisions in invasive breast cancer don’t have to feel like a coin flip. Introducing AidaBreast™-the first test to identify who truly does or does not benefit from radiation therapy. Learn more at ASTRO booth#337 #AidaBreast #BreastCancerCare #ASTRO

PreludeDx (@preludedx) 's Twitter Profile Photo

Join us for the Industry-Expert Theater at #ASTRO25 to discover how new genomic and multi-omic risk assessments can add precision to your radiation treatment decisions. 9/28 @ 2 PM—or join virtually at bit.ly/3InMDsJ #ASTRO2025

Join us for the Industry-Expert Theater at #ASTRO25 to discover how new genomic and multi-omic risk assessments can add precision to your radiation treatment decisions.

9/28 @ 2 PM—or join virtually at bit.ly/3InMDsJ #ASTRO2025
PreludeDx (@preludedx) 's Twitter Profile Photo

You’re invited to Elevate the Night with PreludeDx at #ASTRO25. We’ll provide the cocktails and light bites, and can’t wait to see you there! RSVP early: space is limited! #ASTRO2025 #PreludeDX

You’re invited to Elevate the Night with PreludeDx at #ASTRO25.

We’ll provide the cocktails and light bites, and can’t wait to see you there!

RSVP early: space is limited!

#ASTRO2025 #PreludeDX
ASTRO (@astro_org) 's Twitter Profile Photo

How do genomic and multi-omic tools reshape radiation decisions in early-stage breast cancer? At #ASTRO2025, we’ll explore this in PreludeDx's Industry-Expert Theatre session: From Clin-Path to Precision in Early-Stage Breast Cancer. Sun, 9/28 @ 2PM, Exhibit Hall Theatre 2

How do genomic and multi-omic tools reshape radiation decisions in early-stage breast cancer?
At #ASTRO2025, we’ll explore this in PreludeDx's Industry-Expert Theatre session: From Clin-Path to Precision in Early-Stage Breast Cancer.
Sun, 9/28 @ 2PM, Exhibit Hall Theatre 2
PreludeDx (@preludedx) 's Twitter Profile Photo

PreludeDX is on our way to San Francisco for #ASTRO25! Hear the latest from our Red Journal Clin-Path study, DCISionRT research, and what’s next with AidaBreast. So many ways to connect—we can’t wait to see you! #ASTRO2025

PreludeDX is on our way to San Francisco for #ASTRO25! Hear the latest from our Red Journal 
Clin-Path study, DCISionRT research, and what’s next with AidaBreast. So many ways to connect—we can’t wait to see you! #ASTRO2025
PreludeDx (@preludedx) 's Twitter Profile Photo

Join us for the Industry-Expert Theater at #ASTRO25 to discover how new genomic and multi-omic risk assessments can add precision to your radiation treatment decisions. Live on 9/28 @ 2 PM—or join virtually at bit.ly/3InMDsJ #ASTRO2025

Join us for the Industry-Expert Theater at #ASTRO25 to discover how new genomic and multi-omic risk assessments can add precision to your radiation treatment decisions.

Live on 9/28 @ 2 PM—or join virtually at bit.ly/3InMDsJ

#ASTRO2025
PreludeDx (@preludedx) 's Twitter Profile Photo

How does DCISionRT impact DCIS treatment decisions? That’s the focus of our PREDICT II Registry. The trial is designed to evaluate the clinical utility of DCISionRT. See our featured poster at #ASTRO25: 📍 Poster #2986 📅 Mon, 9/29 | 3 PM PT #ASTRO2025 #DCIS

How does DCISionRT impact DCIS treatment decisions?

That’s the focus of our PREDICT II Registry. The trial is designed to evaluate the clinical utility of DCISionRT.

See our featured poster at #ASTRO25:

📍 Poster #2986
đź“… Mon, 9/29 | 3 PM PT

#ASTRO2025 #DCIS
ASTRO (@astro_org) 's Twitter Profile Photo

You’re invited to PreludeDx's Industry-Expert Theatre at #ASTRO2025! Join PreludeDx's panel as they highlight new Red Journal research and explore how genomic and multi-omic assessments impact your radiation treatment decisions in early-stage breast cancer. 9/28 @ 2PM, Exhibit

You’re invited to PreludeDx's Industry-Expert Theatre at #ASTRO2025!
Join PreludeDx's panel as they highlight new Red Journal research and explore how genomic and multi-omic assessments impact your radiation treatment decisions in early-stage breast cancer.
9/28 @ 2PM, Exhibit
PreludeDx (@preludedx) 's Twitter Profile Photo

Join us tonight to "Elevate the Night” with PreludeDx at #ASTRO25. We’ll provide the cocktails and light bites, and can’t wait to see you there! Stop by Booth #337 for details. #ASTRO2025 #PreludeDX

Join us tonight to "Elevate the Night” with PreludeDx at #ASTRO25.

We’ll provide the cocktails and light bites, and can’t wait to see you there!

Stop by Booth #337 for details.

#ASTRO2025 #PreludeDX
PreludeDx (@preludedx) 's Twitter Profile Photo

There is so much happening at #ASTRO25, and we are thrilled to be here! If you haven’t had the chance to stop by Booth #337 yet, we’d love to see you. #ASTRO2025 #PreludeDx

There is so much happening at #ASTRO25, and we are thrilled to be here!

If you haven’t had the chance to stop by Booth #337 yet, we’d love to see you.

#ASTRO2025 #PreludeDx
PreludeDx (@preludedx) 's Twitter Profile Photo

During Breast Cancer Awareness Month, PreludeDx will donate $10 for every DCISionRT test—to raise $10,000 for advocacy and awareness. Proceeds will go to the Tigerlily FDN, the Breast Cancer Early Detection Coalition, and the Research Advocacy Network. bit.ly/46wLhoN

During Breast Cancer Awareness Month, PreludeDx will donate $10 for every DCISionRT test—to raise $10,000 for advocacy and awareness. Proceeds will go to the Tigerlily FDN, the Breast Cancer Early Detection Coalition, and the Research Advocacy Network. bit.ly/46wLhoN
PreludeDx (@preludedx) 's Twitter Profile Photo

1/4 Proud to team up with sportscaster & DCIS survivor Hannah Storm. Together, we’re raising awareness about #DCIS and empowering women with personalized breast cancer insights this #BreastCancerAwarenessMonth #BreastCancerAwareness #PreludeDx

PreludeDx (@preludedx) 's Twitter Profile Photo

2/4 Hannah Storm sportscaster and #DCIS survivor, shares a few things she wishes she knew when first diagnosed—like the availability of the latest testing to help tailor treatment just for you. Her story brings hope and actionable advice during #BreastCancerAwarenessMonth

PreludeDx (@preludedx) 's Twitter Profile Photo

Drumroll please: We are almost halfway to our goal of informing 1,000 DCISions in the month of October! Thank you for your amazing support! Learn more about our BCAM campaign here: bit.ly/4qdJn4h #EarlyDetectionSavesLives #FindItEarlyAct #TigerlilyFoundation

Drumroll please: We are almost halfway to our goal of informing 1,000 DCISions in the month of October! Thank you for your amazing support! Learn more about our BCAM campaign here: bit.ly/4qdJn4h
#EarlyDetectionSavesLives #FindItEarlyAct #TigerlilyFoundation
PreludeDx (@preludedx) 's Twitter Profile Photo

Our new on-demand webinar, Increasing Confidence and Alleviating Fear with DCISionRT, is now available. Explore the research, clinical application, and patient experience behind DCISionRT. Watch here: bit.ly/47BIXx6 #DCIS #DCISionRT #Oncology #PrecisionMedicine #Webinar

Our new on-demand webinar, Increasing Confidence and Alleviating Fear with DCISionRT, is now available.
Explore the research, clinical application, and patient experience behind DCISionRT.
Watch here: bit.ly/47BIXx6
#DCIS #DCISionRT #Oncology #PrecisionMedicine #Webinar